MOLL FREDERIC H 4

What Happened
Frederic H. Moll, a director of PROCEPT BioRobotics Corp (PRCT), received equity awards on June 9, 2026: 3,315 restricted stock units (RSUs) and a derivative award covering 5,853 shares. Both awards were reported at $0.00 on the Form 4 (i.e., no cash paid by the insider). Combined, the awards cover 9,168 shares and are subject to vesting conditions rather than representing immediately transferable shares.

Key Details

• Transaction date: 2026-06-09; filing date/accession: 2026-06-10 (timely filing).
• Awards: 3,315 RSUs (F1) and 5,853 derivative award (stock option per F2); reported price $0.00.
• Vesting: Per footnotes — RSUs and the stock option vest in full on the earlier of (i) one-year anniversary of the grant or (ii) the next annual meeting, subject to continued service.
• Shares owned after transaction: Not specified in the provided filing.
• This was an award/grant (code A) — a compensation/benefit transaction, not an open-market purchase or sale.

Context
RSUs and option grants are common director/executive compensation and do not by themselves indicate buying or selling sentiment; they represent future rights to stock contingent on vesting and continued service. The option referenced (F2) vests on a similar one-year/annual-meeting schedule; it was granted but not exercised.